Preparation of curcumin-loaded poly(ester amine) nanoparticles for the treatment of anti-angiogenesis

Journal of Biomedical Nanotechnology

Volumn 10, Issue 4, 2014, Pages 632-641

  Ding, Qiuxia ^a   Niu, Ting ^a   Yang, Yi ^a   Guo, Qingfa ^a   Luo, Feng ^a   Qian, Zhiyong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anti Angiogenesis; Curcumin; Poly(ester amine) nanoparticles

Indexed keywords

ANTI-ANGIOGENESIS; AVERAGE PARTICLE SIZE; CURCUMIN; CYTOTOXIC ACTIVITIES; DOUBLE EMULSION-SOLVENT EVAPORATION; DRUG DELIVERY SYSTEM; NARROW SIZE DISTRIBUTIONS; POLY(ESTER AMINE);

CYTOTOXICITY; DRUG DELIVERY; EMULSIFICATION; ESTERIFICATION; ESTERS; FISH; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

NANOPARTICLES;

CURCUMIN; NANOPARTICLE; POLY ESTER AMINE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; SLOW DRUG RELEASE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ZETA POTENTIAL;

ANGIOGENESIS INHIBITORS; ANIMALS; CURCUMIN; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; NANOCAPSULES; NEOVASCULARIZATION, PATHOLOGIC; POLYAMINES; POLYESTERS; TREATMENT OUTCOME; VISCERA; ZEBRAFISH;

EID: 84896764161     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1829     Document Type: Article

References (47)

1. A. Kunnumakkara, P. Anand, and B. Aggarwal, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269, 199 (2008).
2. L. Li, F. Braiteh, and R. Kurzrock, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322 (2005).
3. S. S. Lin, K. C. Lai, S. C. Hsu, and J. S. Yang, Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Lett. 285, 127 (2009).
4. S. T. Tharakan, T. Inamoto, B. Sung, B. B Aggarwal, and A. M. Kamat, Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem. Pharmacol. 79, 218 (2010).
5. J. L. Watson, R. Hill, P. W Lee, C. A. Giacomantonio, and D. W. Hoskin, Curcumin induces apoptosis in HCT-116 human colon cancer cells in a p21-independent manner. Exp. Mol. Pathol. 84, 230 (2008).
6. K. S. Parvathy, P. S. Negi, and P. Srinivas, Antioxidant, antimutagenic and antibacterial activities of curcumin-β-diglucoside. Food Chem. 115, 265 (2009).
7. Y. Deng, W. Wang, P. Yu, Z. Xi, L. Xu, X. Li, and N. He, Comparison of taurine, GABA, Glu, and Asp as scavengers of malondialdehyde in vitro and in vivo. Nanoscale Res. Lett. 8, 190 (2013).
8. Y. Deng, M. Wang, W. Wang, C. Ma, and N. He, Comparison and effects of acute lamotrigine treatment on extracellular excitatory amino acids in the hippocampus of PTZ-kindled epileptic and PTZ-induced status epilepticus rats. Neurochem. Res. 38, 504 (2013).
9. K. Bisht, K. H. Wagner, and A. C. Bulmer, Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology 27, 88 (2010).
10. J. Ravindran, G. V. Subbaraju, M. V. Ramani, B. Sung, and B. B. Aggarwal, Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, antiproliferative and anti-inflammatory activities in vitro. Biochem. Pharmacol. 79, 1658 (2010).
11. P. Anand, B. Sung, A. B. Kunnumakkara, K. N. Rajasekharan, and B. B. Aggarwal, Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: Role of Michael acceptors and Michael donors. Biochem. Pharmacol. 82, 1901 (2011).
12. R. K. Singh, D. Rai, D. Yadav, A. Bhargava, J. Balzarini, and E. De Clercq, Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. Eur. J. Med. Chem. 45, 1078 (2010).
13. J. L. Watson, R. Hill, P. B. Yaffe, A. Greenshields, M. Walsh, P. W. Lee, C. A. Giacomantonio, and D. W. Hoskin, Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett. 297, 1 (2010).
14. T. Sheeja, I. Teruo, B. Sung, A. Bharat, and K. Ashish, AggarwalCurcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem. Pharmacol. 79, 218 (2010).
15. W. Hua, Y. Fu, Y. Liao, W. Xia, and W. Chen, Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur. J. Pharmacol. 637, 16 (2010).
16. J. Seo, K. Jeong, W. Oh, H. Sul, and J. Sohn, Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin. Cancer Lett. 288, 50 (2010).
17. A. B. Fernández-Martínez, A. M. Bajo, A. Valdehita, M. Isabel Arenas, M. Sánchez-Chapado, M. J. Carmena, and J. C. Prieto, Multifunctional role of VIP in prostate cancer progression in a xenograft model: Suppression by curcumin and COX-2 inhibitor NS-398. Peptides 30, 2357 (2009).
18. W. Risau, Mechanisms of angiogenesis. Nature 386, 671 (1997).
19. J. Folkman, Anti-angiogenesis: New concept for therapy of solid tumors. Ann. Surg. 175, 409 (1972).
20. G. Bergers and L. E. Benjamin, Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401 (2003).
21. B. Qu, L. Guo, J. Ma, and Y. Lv, Antiangiogenesis therapy might have the unintended effect of promoting tumor metastasis by increasing an alternative circulatory system. Med. Hypotheses 74, 360 (2010).
22. P. A. Burke and S. J. DeNardo, Antiangiogenic agents and their promising potential in combined therapy. Oncol. Hematol. 39, 155 (2001).
23. A. Morabito, R. Sarmiento, P. Bonginelli, and G. Gasparini, Antiangiogenic strategies, compounds, and early clinical results in breast cancer. Crit. Rev. Oncol. Hematol. 49, 91 (2004).
24. J. L. Arbiser, N. Klauber, R. Rohan, R.van Leeuwen, M. T. Huang, C. Fisher, E. Flynn, and H. R. Byers, Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 4, 376 (1998).
25. S. S. Bhandarkar and J. L. Arbiser, Curcumin as an inhibitor of angiogenesis. Adv. Exp. Med. Biol. 595, 185 (2007).
26. B. Gururaj, D. Venkatesh, D. Marme, and B. Salimath, Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem. Biophys. Res. Commun. 297, 934 (2002).
27. B. B. Aggarwal, Y. J. Surh, and S. Shishodia, The molecular targets and therapeutics use of curcumin in health and disease. Adv. Exp. Med. Biol. 297, 934 (2007).
28. N. S. Rejinold, M. Muthunarayanan, V. V. Divyarani, P. R. Sreerekha, K. P. Chennazhi, S. V. Nair, H. Tamura, and R. Jayakumar, Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. J. Colloid. Interface Sci. 360, 39 (2011).
29. F. Li, X. Li, and B. Li, Preparation of magnetic polylactic acid microspheres and investigation of its releasing property for loading curcumin. J. Magn. Magn. Mater. 323, 2770 (2011).
30. T. Wang, Y. Hu, M. K. Leach, L. Zhang, W. Yang, L. Jiang, Z. Feng, and N. He, Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int. J. Pharm. 422, 462 (2012).
31. W. Yang, T. Wang, J. Fu, and N. He, Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J. Biomed. Nanotechnol. 5, 591 (2009).
32. A. Altunbas, S. J. Lee, S. A. Rajasekaran, J. P. Schneider, and D. J. Pochan, Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles. Biomaterials 32, 5906 (2011).
33. B. Isacchi, M. C. Bergonzi, M. C. Grazioso, C. Righeschi, A. Pietretti, C. Severini, and A. R. Bilia, Artemisinin and artemisinin plus curcumin liposomal formulations: Enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur. J. Pharm. Biopharm. 80, 528 (2012).
34. L. Zhang, Z. Lu, X. Li, Y. Deng, F. Zhang, C. Ma, and N. He, Methoxy poly(ethylene glycol) conjugated denatured bovine serum albumin micelles for effective delivery of camptothecin. Polym. Chem. 3, 1958 (2012).
35. J. Fu, D. Wang, T. Wang, W. Yang, Y. Deng, H. Wang, S. Jin, and N. He, High entrapment efficiency of CS/PLA/TPP nano-sized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
36. H. Maeda, H. Nakamura, and J. Fang, The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv. Drug Deliv. Rev. 65, 71 (2013).
37. Q. Guo, T. Liu, X Yan, and X. Wang, Synthesis and properties of a novel biodegradable poly(ester amine) copolyme based on poly(L-lactide) and low molecular weight polyethylenimine for gene delivery. Int. J. Nanomed. 6, 1641 (2011).
38. J. Hoffmann, M. Schirner, A. Menrad, and M. R. Schneider, A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res. 57, 3847 (1997).
39. F. Alexis, E. Pridgen, L. K. Molnar, and O. C. Farokhzad, Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505 (2008).
40. C. Hea, Y. Hua, L. Yin, C. Tanga, and C. H.Yin, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 21, 3657 (2010).
41. H. Gao, W. Shi, and L. B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102, 9469 (2005).
42. H. Gao, W. Shi, and L. B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl Acad. Sci. 102, 9469 (2005).
43. D. Ravia, K. Ramadasb, B. S. Mathewb, K. R. Nalinakumaric, M. K. Nairb, and M. R. Pillai, Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Oral Oncol. 34, 543 (1998).
44. S. S. Kitambi, K. J. McCulloch, R. T. Peterson, and J. J Malicki, Small molecule screen for compounds that affect vascular development in the zebra fish retina. Mech. Dev. 126, 464 (2009).
45. C. A. MacRae and R. T. Peterson, Zebra fish-based small molecule discovery. Chem. Biol. 10, 901 (2003).
46. M. Gou, K. Men, H. Shi, F. Luo, and Z. Qian, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3, 1558 (2011).
47. C. Gong, S. Deng, and Q. Wu, Improving antiangiogenesis and antitumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34, 1413 (2013).